Increased brain-predicted aging in treated HIV disease

Neurology

Volumn 88, Issue 14, 2017, Pages 1349-1357

  Cole, James H ^a   Underwood, Jonathan ^b   Caan, Matthan W A ^c   De Francesco, Davide ^e   Van Zoest, Rosan A ^c   Leech, Robert ^a   Wit, Ferdinand W N M ^c,f   Portegies, Peter ^c,f,g   Geurtsen, Gert J ^d   Schmand, Ben A ^d   Van Der Loeff, Maarten F Schim ^h   Franceschi, Claudio ⁱ   Sabin, Caroline A ^e   Majoie, Charles B L M ^c   Winston, Alan ^b   Reiss, Peter ^c   Sharp, David J ^a  

^a Division of Brain Sciences   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f STICHTING HIV MONITORING   (Netherlands)

^g OLVG Hospital   (Netherlands)

^h DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; RNA;

ADULT; AGED; ANTIRETROVIRAL THERAPY; ARTICLE; ATTENTION; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE AGING; COGNITIVE DEFECT; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; EXECUTIVE FUNCTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LANGUAGE; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL PERFORMANCE; MOTOR PERFORMANCE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROCESSING SPEED; VIROLOGY; AGING; BLOOD; BRAIN; CLINICAL TRIAL; COGNITION DISORDERS; COMPLICATION; DIAGNOSTIC IMAGING; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PREDICTIVE VALUE; THREE DIMENSIONAL IMAGING;

AGING; BRAIN; COGNITION DISORDERS; FEMALE; HIV; HIV INFECTIONS; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; RNA;

EID: 85017173569     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003790     Document Type: Article

References (40)

1. Althoff KN, McGinnis KA, Wyatt CM, et al. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis 2015;60:627-638.
2. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011;53:1120-1126.
3. Schouten J, Wit FW, Stolte IG, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the ageHIV cohort study. Clin Infect Dis 2014; 59:1787-1797.
4. Kooij KW, Wit FWNM, Schouten J, et al. HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls. AIDS 2016;30:241-250.
5. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet 2013;382:1525-1533.
6. Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 2011;25:561-575.
7. Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 2010;24:1243-1250.
8. Schouten J, Su T, Wit FW, et al. Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy. AIDS 2016; 30:1027-1038.
9. Ritchie SJ, Dickie DA, Cox SR, et al. Brain volumetric changes and cognitive aging during the eighth decade of life. Hum Brain Mapp 2015;36:4910-4925.
10. Ances BM, Ortega M, Vaida F, Heaps J, Paul R. Independent effects of HIV, aging, and HAART on brain volumetric measures. J Acquir Immune Defic Syndr 2012;59:469-477.
11. Becker JT, Maruca V, Kingsley LA, et al. Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology 2012;54:113-121.
12. Cardenas VA, Meyerhoff DJ, Studholme C, et al. Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J Neurovirol 2009;15:324-333.
13. Cohen RA, Harezlak J, Schifitto G, et al. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J Neurovirol 2010;16:25-32.
14. Jernigan TL, Archibald SL, Fennema-Notestine C, et al. Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol 2011;17:248-257.
15. Pfefferbaum A, Rosenbloom MJ, Sassoon SA, et al. Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and age. Biol Psychiatry 2012;72:361-370.
16. Towgood KJ, Pitkanen M, Kulasegaram R, et al. Mapping the brain in younger and older asymptomatic HIV-1 men: frontal volume changes in the absence of other cortical or diffusion tensor abnormalities. Cortex 2012;48:230-241.
17. Kuper M, Rabe K, Esser S, et al. Structural gray and white matter changes in patients with HIV. J Neurol 2011;258: 1066-1075.
18. Heaps JM, Sithinamsuwan P, Paul R, et al. Association between brain volumes and HAND in cART-naive HIV plus individuals from Thailand. J Neurovirol 2015;21:105-112.
19. Wade BS, Valcour VG, Wendelken-Riegelhaupt L, et al. Mapping abnormal subcortical brain morphometry in an elderly HIV1 cohort. NeuroImage Clin 2015;9:564-573.
20. Nir TM, Jahanshad N, Busovaca E, et al. Mapping white matter integrity in elderly people with HIV. Hum Brain Mapp 2014;35:975-992.
21. Pfefferbaum A, Rogosa DA, Rosenbloom MJ, et al. Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study. Neurobiol Aging 2014; 35:1755-1768.
22. Cole JH, Leech R, Sharp DJ; for the Alzheimer's Disease Neuroimaging I. Prediction of brain age suggests accelerated atrophy after traumatic brain injury. Ann Neurol 2015;77:571-581.
23. Gaser C, Franke K, Klöppel S, Koutsouleris N, Sauer H. BrainAGE in Mild cognitive impaired patients: predicting the conversion to Alzheimer's disease. PLoS One 2013;8: e67346.
24. Franke K, Gaser C, Manor B, Novak V. Advanced Brain-AGE in older adults with type 2 diabetes mellitus. Front Aging Neurosci 2013;5:90.
25. Carey CL, Woods SP, Gonzalez R, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 2004;26:307-319.
26. Salthouse TA. Selective review of cognitive aging. J Int Neuropsychol Soc 2010;16:754-760.
27. Salthouse TA. The processing-speed theory of adult age differences in cognition. Psychol Rev 1996;103:403-428.
28. Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 2014;69:833-842.
29. Chang L, Andres M, Sadino J, et al. Impact of apolipoprotein E epsilon4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging. Neuroimage 2011;58:1081-1089.
30. Wendelken LA, Jahanshad N, Rosen HJ, et al. ApoE epsilon4 is associated with cognition, brain integrity and atrophy in HIV over age 60. J Acquir Immune Defic Syndr 2016;73:426-432.
31. Zanet DAL, Thorne A, Singer J, et al. Association between short leukocyte telomere length and HIV infection in a cohort study: No evidence of a relationship with antiretroviral therapy. Clin Infect Dis 2014;58:1322-1332.
32. Horvath S, Levine AJ. HIV-1 infection accelerates age according to the epigenetic clock. J Infect Dis 2015;212: 1563-1573.
33. Chou JP, Ramirez CM, Wu JE, Effros RB. Accelerated aging in HIV/AIDS: novel biomarkers of senescent human CD81 T cells. PLoS One 2013;8:e64702.
34. Gross Andrew M, Jaeger Philipp A, Kreisberg Jason F, et al. Methylome-wide analysis of chronic HIV infection reveals Five-year increase in biological age and epigenetic targeting of HLA. Mol Cell 2016;62:157-168.
35. Rickabaugh TM, Baxter RM, Sehl M, et al. Acceleration of age-associated methylation patterns in HIV-1-infected adults. PLoS One 2015;10:e0119201.
36. Cysique LA, Brew BJ. The effects of HIV and aging on brain functions: proposing a research framework and update on last 3 years' findings. Curr Opin HIV AIDS 2014;9:355-364.
37. Thompson PM, Jahanshad N. Novel neuroimaging methods to understand how HIV affects the brain. Curr HIV/AIDS Rep 2015;12:289-298.
38. Smith RL, de Boer R, Brul S, Budovskaya Y, van der Spek H. Premature and accelerated aging: HIV or HAART? Front Genet 2013;3:328.
39. Su T, Caan MWA, Wit FWNM, et al. White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment. AIDS 2016;30: 311-322.
40. Su T, Wit FW, Caan MW, et al. White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on cART. AIDS 2016; 30:2329-2339.